Combined 3D-QSAR and Molecular Docking Study on benzo[h][1,6]naphthyridin-2(1H)-one Analogues as mTOR Inhibitors

被引:0
作者
Wang, B. [1 ]
Liu, M. M. [1 ]
Wang, B. W. [1 ]
Li, J. [1 ]
Shu, M. [1 ]
Lin, Z. H. [2 ]
机构
[1] Chongqing Univ Technol, Dept Pharm & Bioengn, Chongqing 400054, Peoples R China
[2] Chongqing Univ, Dept Chem & Chem Engn, Chongqing 400044, Peoples R China
关键词
mTOR; 3D-QSAR; CoMFA; CoMSIA; molecular docking; MAMMALIAN TARGET; 3-KINASE/MAMMALIAN TARGET; DISCOVERY; CANCER; OPTIMIZATION; DERIVATIVES; NVP-BEZ235; DESIGN; GROWTH; POTENT;
D O I
10.4172/pharmaceutical-sciences.1000331
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Mechanistic target of rapamycin is involved in the formation of tumor microvasculature was an ideal target for computer-aided drug design. The predictive study of quantitative structure-activity relationship and molecular docking can shorten the cycle and reduce the cost of designing the higher activity mTOR inhibitors. In this article, comparative molecular field analysis and comparative molecular similarity indices analysis fields were used to analyse three-dimensional quantitative structure-activity relationship model. The model (comparative molecular similarity indices analysis with q(2)=0.607, r(2)=0.909; comparative molecular similarity indices analysis with q(2)=0.703, r(2)=0.935) has a good predictability. Three-dimensional quantitative structure-activity relationship model contour maps indicate the electrostatic, hydrophobic and hydrogen bond donor fields have crucial effects to derivatives biological activity. Molecular docking was employed to explore the conformations of 55 compounds with key amino acid residues. Finally, combining contour maps with molecular docking results, ten derivatives as potential mechanistic target of rapamycin inhibitors were designed to further verify established three-dimensional quantitative structure-activity relationship models. These data provide significant theoretical foundation for designing better activity mechanistic target of rapamycin inhibitors.
引用
收藏
页码:65 / 78
页数:14
相关论文
共 30 条
[1]   STRUCTURAL BIOLOGY Architecture of human mTOR complex 1 [J].
Aylett, Christopher H. S. ;
Sauer, Evelyn ;
Imseng, Stefan ;
Boehringer, Daniel ;
Hall, Michael N. ;
Ban, Nenad ;
Maier, Timm .
SCIENCE, 2016, 351 (6268) :48-52
[2]   Three-dimensional quantitative structure-activity relationship (3D-QSAR) analysis and molecular docking-based combined in silico rational approach to design potent and novel TRPV1 antagonists [J].
Bhadoriya, Kamlendra Singh ;
Sharma, Mukesh C. ;
Jain, Shailesh V. ;
Raut, Ganesh S. ;
Rananaware, Jyotsna R. .
MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (05) :2312-2327
[3]   Lead Optimization of N-3-Substituted 7-Morpholinotriazolopyrimidines as Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of PKI-402 [J].
Dehnhardt, Christoph M. ;
Venkatesan, Aranapakam M. ;
Delos Santos, Efren ;
Chen, Zecheng ;
Santos, Osvaldo ;
Ayral-Kaloustian, Semiramis ;
Brooijmans, Natasja ;
Mallon, Robert ;
Hollander, Irwin ;
Feldberg, Larry ;
Lucas, Judy ;
Chaudhary, Inder ;
Yu, Ker ;
Gibbons, Jay ;
Abraham, Robert ;
Mansour, Tarek S. .
JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (02) :798-810
[4]  
Fan QW, 2012, METHODS MOL BIOL, V821, P349, DOI 10.1007/978-1-61779-430-8_22
[5]   Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony [J].
Foster, Kathryn G. ;
Fingar, Diane C. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (19) :14071-14077
[6]   The synergistic interaction of MEK and PI3K inhibitors is modulated by mTOR inhibition [J].
Haagensen, E. J. ;
Kyle, S. ;
Beale, G. S. ;
Maxwell, R. J. ;
Newell, D. R. .
BRITISH JOURNAL OF CANCER, 2012, 106 (08) :1386-1394
[7]   Comparative QSAR: Toward a deeper understanding of chemicobiological interactions [J].
Hansch, C ;
Hoekman, D ;
Gao, H .
CHEMICAL REVIEWS, 1996, 96 (03) :1045-1075
[8]   3D-QSAR studies of latrunculin-based actin polymerization inhibitors using CoMFA and CoMSIA approaches [J].
Khanfar, Mohammad A. ;
Youssef, Diaa T. A. ;
El Sayed, Khalid A. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) :3662-3668
[9]   mTOR: a pharmacologic target for autophagy regulation [J].
Kim, Young Chul ;
Guan, Kun-Liang .
JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (01) :25-32
[10]   Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer [J].
Korets, Sharmilee Bansal ;
Musa, Fernanda ;
Curtin, John ;
Blank, Stephanie V. ;
Schneider, Robert J. .
GYNECOLOGIC ONCOLOGY, 2014, 132 (02) :468-473